Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
NCT03015324
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
Hydroxychloroquine
Sponsor
Peng Wang, MD PhD